Guardant Health Inc (NASDAQ:GH) shares, rose in value, with the stock price down by -5.19% to the previous day’s close as strong demand from buyers drove the stock to $17.16.
Actively observing the price movement in the last trading, the stock closed the session at $18.10. Referring to stock’s 52-week performance, its high was $41.06, and the low was $15.81. On the whole, GH has fluctuated by -3.00% over the past month.
Projections by analysts suggest varying estimates for the company’s quarterly revenue. Analysts have estimated the company’s revenue for the quarter at 664.02M, with a low estimate of 147.6M and a high estimate of 161.9M. Wall Street analysts also predicted that the company’s y-o-y revenues would reach 150.67M.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that GH’s technical picture suggests that short-term indicators denote the stock is a 100% Sell on average. However, medium-term indicators have put the stock in the category of 100% Sell while long-term indicators on average have been pointing out that it is a 100% Sell.
The stock’s technical analysis shows that the PEG ratio is about 0, with the price of GH currently trading nearly -5.82% and -9.43% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 44.94, while the 7-day volatility ratio is showing 5.40% which for the 30-day chart, stands at 7.06%. Furthermore, Guardant Health Inc (GH)’s beta value is 0.92, and its average true range (ATR) is 1.15.
A comparison of Guardant Health Inc (GH) with its peers suggests the former has fared considerably weaker in the market. GH showed an intraday change of -5.19% in last session, and over the past year, it shrunk by -20.00%%.
Data on historical trading for Guardant Health Inc (NASDAQ:GH) indicates that the trading volumes over the past 3 months, they’ve averaged 1.97 million. According to company’s latest data on outstanding shares, there are 121.63 million shares outstanding.
Nearly 4.79% of Guardant Health Inc’s shares belong to company insiders and institutional investors own 93.88% of the company’s shares. The stock has fallen by -36.56% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the GH stock heading into the next quarter.
